ParkerVision reports 2023 net income of $9.5M vs loss of $9.8M in 2022; patent trial dates set

PARKERVISION INC

Net income $9.5M (EPS $0.11 basic, $0.08 diluted) vs net loss $9.8M in 2022.
Revenue increased $24.1M from patent licensing and enforcement, including a $25M settlement in 2023.
Repaid $13.9M on secured contingent debt; borrowed $5M at lower rate; extended $1.2M convertible debt maturities by 2+ years.
Jury trials scheduled: MediaTek Dec 2024, Realtek Jan 2025; CAFC appeal on Qualcomm case pending.
Cash $2.6M at Dec 31, 2023; accounts payable reduced 36%.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

PARKERVISION INC reported the year ended December 31, 2023 results: revenue $24.1 million increase in revenue, net income $9.5 million, EPS $0.11 and $0.08 respectively for 2023.

Period: the year ended December 31, 2023
Revenue: $24.1 million increase in revenue
Net income: $9.5 million
EPS: $0.11 and $0.08 respectively for 2023
Result: reported results

Exact text from the filing

for 2023, compared to basic and diluted loss per common share of $(0.13) in 2022. o The $19.3 million increase in earnings from 2022 to 2023 is primarily the result of a $24.1 million increase in revenue resulting from our patent enforcement and licensing efforts, a $2.6 million decrease in the loss related to the change in fair value of our contingent payment

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

PARKERVISION INC filing history →

Source: SEC EDGAR

accession 0001437749-24-008857

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.